ConductScience.org, home

Paper381925

Marrow transplantation for acute nonlymphoblastic leukemia in first remission.

Thomas ED and 11 others. N Engl J Med, 1979. Cited by 689 papers, by iCite.

Cite this record

ConductScience Library. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. Papers, record 381925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/381925

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Marrow transplantation for acute nonlymphoblastic leukemia in first remission.
PubMed
Journal
N Engl J Med
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
689
iCite
Relative citation ratio, by iCite
16.2
iCite
Revised in PubMed
2007-11-15
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thomas EDE D
2Buckner CDC D
3Clift RAR A
4Fefer AA
5Johnson FLF L
6Neiman PEP E
7Sale GEG E
8Sanders JEJ E
9Singer JWJ W
10Shulman HH
11Storb RR
12Weiden PLP L

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone Marrow TransplantationMajor topic
LeukemiaMajor topic
Acute Disease
Adolescent
Adult
Child
Humans
Leukemia, Monocytic, Acute
Leukemia, Myeloid
Leukemia, Myeloid, Acute
Middle Aged
Remission, Spontaneous
Time Factors
Transplantation, Homologous

Source PubMed

Download CSV of topics

Cited by101

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 689 citations.

PMIDTitleJournalYearIn PapersSource
41462915Allogeneic Hematopoietic Stem Cell Transplantation as a Therapeutic Approach for Hereditary Diseases.Biomedicines2025https://conductscience.org/library/papers/41462915PubMed
41331040The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation.Bone Marrow Transplant2026https://conductscience.org/library/papers/41331040PubMed
40207714Reduced incidence of relapse and graft-versus-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation.Haematologica2025https://conductscience.org/library/papers/40207714PubMed
40100591Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.Methods Mol Biol2025https://conductscience.org/library/papers/40100591PubMed
39147891Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings.Bone Marrow Transplant2024https://conductscience.org/library/papers/39147891PubMed
38909530Cancer treatments: Past, present, and future.Cancer Genet2024https://conductscience.org/library/papers/38909530PubMed
38571944Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect.Front Immunol2024https://conductscience.org/library/papers/38571944PubMed
38181752Hallmarks of stemness in mammalian tissues.Cell Stem Cell2024https://conductscience.org/library/papers/38181752PubMed
38098489Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development.Front Immunol2023https://conductscience.org/library/papers/38098489PubMed
37627165Immunotherapy in Acute Leukemias: Past Success Paves the Way for Future Progress.Cancers (Basel)2023https://conductscience.org/library/papers/37627165PubMed
36698790Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders.Front Genome Ed2022https://conductscience.org/library/papers/36698790PubMed
36341432Antibody based conditioning for allogeneic hematopoietic stem cell transplantation.Front Immunol2022https://conductscience.org/library/papers/36341432PubMed
35926108Single-cell genomics in AML: extending the frontiers of AML research.Blood2023https://conductscience.org/library/papers/35926108PubMed
35318487Twenty years of experience of a tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignancies.Strahlenther Onkol2022https://conductscience.org/library/papers/35318487PubMed
35242706Role of Radiation Based Conditioning Regimens in Patients With High-Risk AML Undergoing Allogenic Transplantation in Remission or Active Disease and Mechanisms of Post-Transplant Relapse.Front Oncol2022https://conductscience.org/library/papers/35242706PubMed
35053386Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on "Off-the-Shelf" T Cell Therapy Using iPSC Technology and Gene Editing.Cells2022https://conductscience.org/library/papers/35053386PubMed
34864823Differentiation therapy for myeloid malignancies: beyond cytotoxicity.Blood Cancer J2021https://conductscience.org/library/papers/34864823PubMed
34831068From Hematopoietic Stem Cell Transplantation to Chimeric Antigen Receptor Therapy: Advances, Limitations and Future Perspectives.Cells2021https://conductscience.org/library/papers/34831068PubMed
34750175Hematopoietic Stem Cells and Regeneration.Cold Spring Harb Perspect Biol2022https://conductscience.org/library/papers/34750175PubMed
34595407Current Status and Perspectives of Irradiation-Based Conditioning Regimens for Patients with Acute Leukemia Undergoing Hematopoietic Stem Cell Transplantation.Clin Hematol Int2019https://conductscience.org/library/papers/34595407PubMed

See all 101 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/381925

GET https://conductscience.org/api/papers/v1/381925/cited_by?page=2